# Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study

> **NCT06698510** · — · RECRUITING · sponsor: **Peter Steinmann** · enrollment: 18500 (estimated)

## Conditions studied

- Schistosomiasis

## Interventions

- **DRUG:** Arpraziquantel 150mg dispersible tablet

## Key facts

- **NCT ID:** NCT06698510
- **Lead sponsor:** Peter Steinmann
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-25
- **Primary completion:** 2025-11
- **Final completion:** 2026-03
- **Target enrollment:** 18500 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06698510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06698510, "Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06698510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*